Silvia Sabbioni

Department of Life Sciences and Biotechnology, University of ferrara

Research Area

Bioengineering

Biography

Silvia Sabbioni has not added Biography.
If you are Silvia Sabbioni and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2016

Other Publications

Article	Year
Simian virus 40 infection in humans and association with human diseases: results and hypotheses. Virology\| PubMed ID: 15015494	2004
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology\| PubMed ID: 15068392	2003
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer research\| PubMed ID: 15548679	2004
MicroRNA gene expression deregulation in human breast cancer. Cancer research\| PubMed ID: 16103053	2005
BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors. Advances in experimental medicine and biology\| PubMed ID: 16626046	2006
Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. Molecular cancer\| PubMed ID: 17328794	2007
MicroRNAs in human cancer: from research to therapy. Journal of cell science\| PubMed ID: 17515481	2007
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer research\| PubMed ID: 17616664	2007
Simian virus 40 in humans. Infectious agents and cancer\| PubMed ID: 17620119	2007
Open letter to Senator Rita Levi-Montalcini. Science (New York, N.Y.)\| PubMed ID: 18356504	2008
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free radical biology & medicine\| PubMed ID: 19022373	2009
MicroRNA involvement in hepatocellular carcinoma. Journal of cellular and molecular medicine\| PubMed ID: 19120703	2008
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer research\| PubMed ID: 19584283	2009
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19671867	2009
MicroRNA response to environmental mutagens in liver. Mutation research\| PubMed ID: 21514310	2011
microRNA involvement in hepatocellular carcinoma. Anti-cancer agents in medicinal chemistry\| PubMed ID: 21554203	2011
MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)\| PubMed ID: 22179688	2012
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. The Journal of pathology\| PubMed ID: 22262409	2012
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology (Baltimore, Md.)\| PubMed ID: 22473819	2012
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs. Frontiers in genetics\| PubMed ID: 23630541	2013
Role of microRNAs in hepatocellular carcinoma: a clinical perspective. OncoTargets and therapy\| PubMed ID: 24039437	2013
Anti-tumor activity of a miR-199-dependent oncolytic adenovirus. PloS one\| PubMed ID: 24069256	2013
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma. Molecular cancer research : MCR\| PubMed ID: 24324033	2014
microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24916701	2014
Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma. Gastroenterology and hepatology from bed to bench\| PubMed ID: 25436097	2014
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget\| PubMed ID: 26090867	2015
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR. Biomarker research\| PubMed ID: 26120471	2015
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine\| PubMed ID: 26288818	2015
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients. BMC cancer\| PubMed ID: 26508446	2015
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma. Oncotarget\| PubMed ID: 27120784	2016